Gennex Lab, a company in the Pharmaceuticals industry, reported revenue of ₹40 crore and net profit of ₹4.67 crore for the June 2026 quarter.
Gennex Lab. (BSE: GENNEX) closed at ₹8.84 on 20 Nov 2026, down 38.7% over the past year. Its market capitalisation is ₹215 crore and it trades at 11.4 times earnings.
Incorporated in 1995, Gennex Laboratories Ltd manufactures Bulk Drugs and Intermediaries
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.